Osimertinib 80mg tablets
NHS hospitals in England used £132,326,740 of indicative cost of Osimertinib 80mg tablets in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 6.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Osimertinib 80mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Osimertinib 80mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £6,247,279 |
| The Christie Nhs Foundation Trust | £5,690,370 |
| The Clatterbridge Cancer Centre Nhs Ft | £5,131,835 |
| Guy's & St Thomas' Nhs Foundation Trust | £4,328,267 |
| Barts Health Nhs Trust | £3,417,761 |
| Manchester University Nhs Ft | £3,066,753 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,016,939 |
| Sheffield Teaching Hospitals Nhs Trust | £2,817,489 |
| Royal Surrey County Hosp Nhs Found Trust | £2,661,315 |
| Maidstone And Tunbridge Wells Nhs Trust | £2,433,015 |
The primary-care picture
Osimertinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Osimertinib medicine page.